This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of adding a new drug to the current triple-drug regimen for management of resistant hypertension in adults versus continuation of treatment with triple-drug therapy alone.
CITATION STYLE
Charan, J., Chaudhari, M., Mulla, S., Reljic, T., Mhaskar, R., & Kumar, A. (2017). Pharmacotherapy for resistant hypertension in adults. Cochrane Database of Systematic Reviews, 2017(8). https://doi.org/10.1002/14651858.CD012769
Mendeley helps you to discover research relevant for your work.